Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 1/20 | 0.70 |
| ▸ | NAAA | Q02083 | 1/20 | 0.69 |
| ▸ | RAD52 | P43351 | 1/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.58 |
| ▸ | DGKA | P23743 | 1/20 | 0.57 |
| ▸ | FAAH | O00519 | 2/20 | 0.56 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.53 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.53 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.53 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27918118 | 1.00 | HTR2C (0.70) | HTR2CNAAARAD52NPSR1DGKA | |
| SCHEMBL6380882 | 1.00 | HTR2C (0.70) | HTR2CNAAARAD52NPSR1DGKA | |
| SCHEMBL7780438 | 1.00 | HTR2C (0.70) | HTR2CNAAARAD52NPSR1DGKA | |
| SCHEMBL2269645 | 1.00 | HTR2C (0.70) | HTR2CNAAARAD52NPSR1DGKA | |
| SCHEMBL580166 | 1.00 | HTR2C (0.70) | HTR2CNAAARAD52NPSR1DGKA | |
| SCHEMBL410582 | 1.00 | HTR2C (0.70) | HTR2CNAAARAD52NPSR1DGKA | |
| SCHEMBL10626588 | 1.00 | HTR2C (0.70) | HTR2CNAAARAD52NPSR1DGKA | |
| SCHEMBL5153816 | 1.00 | HTR2C (0.70) | HTR2CNAAARAD52NPSR1DGKA | |
| SCHEMBL2763091 | 1.00 | HTR2C (0.70) | HTR2CNAAARAD52NPSR1DGKA | |
| SCHEMBL27505167 | 1.00 | HTR2C (0.70) | HTR2CNAAARAD52NPSR1DGKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12533421-B2 | Methods for making multilayered vesicles | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 2026-01-27 | — | — | US | claimed |
| US-20220257791-A1 | METHODS FOR MAKING MULTILAYERED VESICLES | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND | 2022-08-18 | — | — | US | claimed |
| US-12533421-B2 | Methods for making multilayered vesicles | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 2026-01-27 | — | — | US | disclosed |
| US-12397057-B2 | Hydrophobically modified polypeptoids and uses thereof | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 2025-08-26 | — | — | US | disclosed |
| US-20220257791-A1 | METHODS FOR MAKING MULTILAYERED VESICLES | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND | 2022-08-18 | — | — | US | disclosed |
| US-20220072135-A1 | HYDROPHOBICALLY MODIFIED POLYPEPTOIDS AND USES THEREOF | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND | 2022-03-10 | — | — | US | disclosed |
| EP-3960153-A1 | SKINCARE COMPOSITION FOR TIGHTENING SKIN, AND PREPARATION METHOD THEREFOR | Zhejiang Kangmanjia Daily Necessities Co., Ltd. (CN) | 2022-03-02 | — | — | EP | disclosed |
| US-11123433-B2 | Hydrophobically modified polypeptoids and uses thereof | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY (US) | 2021-09-21 | — | — | US | disclosed |
| US-10384247-B2 | Process for obtaining ionic amino acid esters | INSTITUTO MEXICANO DEL PETROLEO (MX) | 2019-08-20 | — | — | US | disclosed |
| US-20190185622-A1 | HYDROPHOBICALLY MODIFIED POLYPEPTOIDS AND USES THEREOF | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND | 2019-06-20 | — | — | US | disclosed |
| US-9677009-B2 | Process for demulsification of crude oil in water emulsions by means of natural or synthetic amino acid-based demulsifiers | INSTITUTO MEXICANO DEL PETROLEO (MX) | 2017-06-13 | — | — | US | disclosed |
| CN-1729014-A | Methods of treating diseases by antimicrobial peptide inhibitors | YITZCHAK HILLMAN (IL) | 2006-02-01 | — | — | CN | disclosed |
| CN-1694719-A | Casein derived peptides and therapeutic uses thereof | CHAY 13 MEDICAL RES GROUP N V (AN) | 2005-11-09 | — | — | CN | disclosed |
| CN-1691889-A | Curing and preventing method | WALTER & ELESARHOL MEDICAL ACA (AU) | 2005-11-02 | — | — | CN | disclosed |
| CN-1596264-A | Differentially expressed genes related to obesity and type 2 diabetes | AUTOGEN RES PTY LTD (AU) | 2005-03-16 | — | — | CN | disclosed |
| CN-1531554-A | Humanized antibodies derived from DD-3B 6/22 specific for the D-dimer fragment of fibrin | ��������ҽѧ����˾ | 2004-09-22 | — | — | CN | disclosed |
| WO-2004074235-A1 | TRANSDERMAL PENETRATION ENHANCERS | UNIVERZITA KARLOVA V PRAZE Farmaceuticka Fakulta V Hradci Kralové (CZ) | 2004-09-02 | — | — | WO | disclosed |
| CN-1520310-A | Use of angiotensin I derivatives as agents for the treatment and prevention of infarction-related cardiac injuries and disorders | 新加坡国立大学 | 2004-08-11 | — | — | CN | disclosed |
| CN-1494592-A | Nucleic acid expressed in hypothalamus or muscle tissue in obese animals | ���и��о��ɷ�����˾ | 2004-05-05 | — | — | CN | disclosed |
| CN-1427725-A | Casein derived peptides and therapeutic uses thereof | CHAY 13 MEDICAL RES GROUP N V (NL) | 2003-07-02 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12533421-B2 | Methods for making multilayered vesicles | CHMP4B, NPC1L1, LIPA | HTR2C 1932/4885NAAA 3881/4885RAD52 4707/4885 |
| US-10384247-B2 | Process for obtaining ionic amino acid esters | BCAT2, BCAT1, FASN | HTR2C 1870/4885NAAA 215/4885RAD52 4511/4885 |
| US-11123433-B2 | Hydrophobically modified polypeptoids and uses thereof | SIN3A, PHLPP2, NUP188 | HTR2C 2080/4885NAAA 1147/4885RAD52 2931/4885 |
| US-20190185622-A1 | HYDROPHOBICALLY MODIFIED POLYPEPTOIDS AND USES THEREOF | SIN3A, PHLPP2, NUP188 | HTR2C 2080/4885NAAA 1147/4885RAD52 2931/4885 |
| US-20220257791-A1 | METHODS FOR MAKING MULTILAYERED VESICLES | CHMP4B, VCL, LIPA | HTR2C 1867/4885NAAA 3094/4885RAD52 4345/4885 |
| US-20220072135-A1 | HYDROPHOBICALLY MODIFIED POLYPEPTOIDS AND USES THEREOF | SIN3A, PHLPP2, PHLPP1 | HTR2C 2603/4885NAAA 2010/4885RAD52 2763/4885 |
| US-12397057-B2 | Hydrophobically modified polypeptoids and uses thereof | SIN3A, PHLPP2, NUP188 | HTR2C 2080/4885NAAA 1147/4885RAD52 2931/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.